Business Insider examined similarities between mistakes made in Ebola research and coronavirus cure research. CP3 Director Dr. Walid Gellad noted that "it’s a legitimate worry that the torrent of studies will compete for the same pool of patients, making it harder to find enough people to test all the drugs."